Objectives: To assess the immediate response to the first dose of Covishield vaccine and to study the side effects of vaccination. Results: Results of the study revealed that 148(98.66%) participants are not developed any side effects, only 2 (1.33%) participants reported mild side effects within 30 minutes after vaccination, 112 (74.66%) participants are developed mild side effects like fever, body pain after 30 minutes to 24 hours, no participants are developed side effects after 1 week of vaccination, none of the participants didn't required any hospitalization, All the participants are willing to take 2nd dose and recommend for their family members and friends to get vaccination.
Cite this article:
Manjula K.V., Simi Thamous. A Study to assess side effects of first dose of Covshield Vaccine among adults residing in Rajiv Nagar Mysore. Asian Journal of Nursing Education and Research. 2022; 12(1):135-7. doi: 10.52711/2349-2996.2022.00029
Manjula K.V., Simi Thamous. A Study to assess side effects of first dose of Covshield Vaccine among adults residing in Rajiv Nagar Mysore. Asian Journal of Nursing Education and Research. 2022; 12(1):135-7. doi: 10.52711/2349-2996.2022.00029 Available on: https://ajner.com/AbstractView.aspx?PID=2022-12-1-29
2. Ruan, S. (2020). Likelihood of survival of coronavirus disease 2019. The Lancet Infectious Diseases, 20(6), 630–631)
3. Chopra S., Ranjan P., Singh V., Kumar S., Arora M., Hasan M.S. Impact of COVID-19 on lifestyle-related behaviours- a cross-sectional audit of responses from nine hundred and ninety-five participants from India. Diabetes Metab Syndr. 2020;14(6):2021–2030. [PMC free article] [PubMed] [Google Scholar
6. Central Drugs Standard Control Organization (CDSCO